Characteristics by physician-assigned severity of asthma, asthma+COPD and COPD patients in the NOVELTY study

J. Vestbo (Manchester, United Kingdom), H. Reddel (Sydney, Australia), A. Agustí (Barcelona, Spain), E. Bel (Amsterdam, Netherlands), C. Janson (Uppsala, Sweden), B. Make (Denver, CO, United States of America), D. Price (Aberdeen, United Kingdom), R. Hughes (Cambridge, United Kingdom), E. Rapsomaniki (Cambridge, United Kingdom), N. Karlsson (Gothenburg, Sweden), J. Nuevo (Madrid, Spain), S. Rennard (Cambridge, United Kingdom), A. De Giorgio-Miller (Cambridge, United Kingdom), M. Alacqua (Cambridge, United Kingdom), M. Gerhardsson De Verdier (Gothenburg, Sweden)

Source: International Congress 2019 – Clinical implications of asthma management
Session: Clinical implications of asthma management
Session type: Poster Discussion
Number: 5029
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Vestbo (Manchester, United Kingdom), H. Reddel (Sydney, Australia), A. Agustí (Barcelona, Spain), E. Bel (Amsterdam, Netherlands), C. Janson (Uppsala, Sweden), B. Make (Denver, CO, United States of America), D. Price (Aberdeen, United Kingdom), R. Hughes (Cambridge, United Kingdom), E. Rapsomaniki (Cambridge, United Kingdom), N. Karlsson (Gothenburg, Sweden), J. Nuevo (Madrid, Spain), S. Rennard (Cambridge, United Kingdom), A. De Giorgio-Miller (Cambridge, United Kingdom), M. Alacqua (Cambridge, United Kingdom), M. Gerhardsson De Verdier (Gothenburg, Sweden). Characteristics by physician-assigned severity of asthma, asthma+COPD and COPD patients in the NOVELTY study. 5029

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort
Source: Eur Respir J, 58 (3) 2003927; 10.1183/13993003.03927-2020
Year: 2021



Distribution of T2 markers in real-life patients with asthma, COPD and asthma+COPD from the BREATHE study
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020


Factors associated with exacerbations in patients with COPD: NOVELTY study
Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Year: 2020


Clinical characteristics of patients with frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS)
Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care
Year: 2016


An acute bronchitis questionnaire (AECB-SS) discriminates between GOLD categories for COPD severity in patients screened for the MOSAIC study
Source: Eur Respir J 2004; 24: Suppl. 48, 239s
Year: 2004

Comorbidities in Swedish COPD and non-COPD patients: ARCTIC study
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016

Influence of the seasons on exacerbation characteristics in a cohort of COPD patients (EXACO study)
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013


Factors associated with physician assessment of severity of asthma or COPD in NOVELTY
Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases
Year: 2020


Comparison of spirometric markers of severity and reversibility in patients with asthma and/or COPD in NOVELTY
Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases
Year: 2020




Evaluation of asthma/COPD overlap within the ECLIPSE study
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015


The prevalence and clinical characteristics of asthma–COPD overlap syndrome (ACOS) in patients with COPD
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017

Impact of age-related comorbidities on the risk of COPD exacerbations in subjects with severe airflow limitation: A pan-European study
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013

Baseline symptom scores and future risk of severe exacerbation: The SPARK study
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015


Top-10 comorbidities of symptomatic patients with moderate COPD in the clinical setting of the CRYSTAL study
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016


Measuring exacerbations in subjects with mild to moderate COPD from a population-based cohort: The CanCOLD study
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013


LATE-BREAKING ABSTRACT: Baseline demographic and clinical profile of patients with and without cardiovascular diseases in the assessment of comorbidities in COPD in european symptomatic subjects from primary care (ACCESS) study
Source: Annual Congress 2013 –A modern approach to lung diseases: from bronchi to pleura
Year: 2013


The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013


COPD patients with asthma, characteristics and risk of exacerbations
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019

Comparing the prevalence of depression and anxiety in patients admitted with an exacerbation of COPD using two scoring systems
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015


Clinical factors associated with baseline blood eosinophils among patients with asthma or COPD: NOVELTY study
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020